ARMP
Armata Pharmaceuticals Inc
3.70$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.2 | -8.5 | -10 | -13 | -5.8 | -11 | -0.6 | -24 | -20 | -11 | -16 | -16 | -12 | -14 | -10 | -4.7 | -4.3 | -7.4 | -13 | -9.8 | -11 | -9.2 | -9.4 | -16 | -18 | -24 | -32 | -47 | -38 | -26 | |
| 1.3 | 1.4 | 1.9 | 1.6 | 1.6 | 1.6 | 3.5 | 8.7 | 3.6 | 2.4 | 1.3 | 1.3 | 0.7 | 0.6 | 0.5 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 1.4 | 1.1 | 1.2 | 0.9 | 1.0 | 1.3 | 1.5 | |
| – | – | – | – | – | – | – | 0.1 | – | – | – | – | – | 1.0 | 0.7 | – | 0.0 | 1.4 | 1.9 | 0.5 | 2.0 | 0.7 | 0.5 | 4.3 | 3.5 | 2.9 | 3.1 | 0.9 | 2.9 | 2.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 5.2 | 4.7 | 3.7 | 3.4 | 3.9 | – | – | – | |
| 0.1 | 3.2 | 0.9 | 6.5 | 0.2 | -1.3 | -3.2 | -8.8 | -2.8 | 0.4 | -1.6 | 1.4 | -0.5 | 0.4 | 1.4 | -4.3 | -0.2 | 1.1 | -0.6 | -0.2 | 0.7 | -0.5 | 0.3 | -2.2 | -0.9 | -3.2 | 0.4 | -9.6 | -2.1 | -1.4 | |
| 0.9 | 1.3 | 1.5 | 0.7 | 0.2 | 1.9 | 2.8 | 4.4 | 0.6 | 0.3 | 0.4 | 0.7 | 0.1 | 0.6 | 0.7 | 0.1 | 0.1 | 0.1 | 1.2 | 0.2 | 0.3 | 0.1 | 0.0 | 0.1 | 0.8 | 1.3 | 2.2 | 8.1 | 1.9 | 0.5 | |
| -4.7 | -4.3 | -3.3 | 11 | -6.2 | 5.1 | -2.2 | -7.2 | -2.5 | -0.3 | -0.4 | -0.6 | 0.0 | -0.5 | -0.7 | – | 3.1 | -0.1 | -1.2 | -0.2 | -0.3 | -0.1 | 0.0 | 2.9 | -0.8 | -1.3 | -2.2 | -8.1 | -1.9 | -0.5 | |
| – | – | – | – | – | 0.4 | – | 0.9 | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13 | -0.2 | 9.5 | 12 | 10.0 | 23 | 27 | 45 | 0.0 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.7 | 0.7 | 0.7 | 0.7 | 0.0 | -0.5 | 54 | 35 | 25 | |
| 13 | 13 | 15 | -0.5 | 13 | 7.8 | 37 | 17 | 10 | 20 | 29 | -3.0 | 3.8 | 25 | -0.3 | 2.5 | 1.0 | 27 | – | 13 | 7.2 | 8.7 | 12 | 9.0 | 23 | 26 | 44 | 54 | 35 | 26 | |
| -1.2 | -2.3 | -2.2 | -2.5 | -1.0 | 2.2 | 35 | -13 | -13 | 8.5 | 13 | -20 | -7.9 | 10 | -11 | -2.3 | -0.2 | 19 | -14 | 2.8 | -3.7 | -0.6 | 3.0 | -3.7 | 4.1 | 0.6 | 4.6 | -1.6 | -4.5 | -0.7 | |
| -8.1 | -9.8 | -12 | -13 | -6.0 | -13 | -3.4 | -28 | -21 | -12 | -16 | -17 | -12 | -14 | -11 | -4.8 | -4.3 | -7.6 | -14 | -10.0 | -11 | -9.3 | -9.4 | -16 | -19 | -25 | -35 | -56 | -39 | -26 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.